Related Experiment Video

Updated: Jul 11, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

Alcohol septal ablation versus surgical myectomy: a patient with obstructive HCM

Giovanni La Canna1, Flavio Airoldi, Elvia Capritti

  • 1Echocardiography Unit, Cardiac Surgery Department, Vita-Salute San Raffaele University, Milan, Italy. lacanna.giovanni@hsr.it

Nature Clinical Practice. Cardiovascular Medicine
|September 26, 2007
PubMed

Insights

A patient with obstructive hypertrophic cardiomyopathy unsuitable for alcohol septal ablation underwent successful surgical myectomy. Intraoperative echocardiography guided the procedure, offering an alternative treatment for severe symptoms.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Imaging

Background:

  • A 42-year-old woman with a 20-year history of symptomatic obstructive hypertrophic cardiomyopathy (oHCM) presented with worsening symptoms despite medical management.
  • The patient was referred for consideration of alcohol septal ablation, a minimally invasive treatment option for oHCM.

Observation:

  • Comprehensive diagnostic workup included physical examination, electrocardiography, echocardiography (rest-exercise Doppler, 2D, intracoronary myocardial contrast, intraoperative transesophageal, and epicardial), and coronary angiography.
  • The patient was determined to be unsuitable for alcohol septal ablation due to specific anatomical or physiological factors.

Findings:

  • Surgical myectomy was performed as an alternative therapeutic strategy.
  • Intraoperative echocardiography played a crucial role in guiding the surgical myectomy procedure, ensuring precision and effectiveness.

Implications:

  • This case highlights the importance of multimodal imaging, particularly intraoperative echocardiography, in guiding surgical interventions for complex cardiac conditions like oHCM.
  • Surgical myectomy remains a viable and effective treatment option for carefully selected patients with obstructive hypertrophic cardiomyopathy who are not candidates for septal ablation.
  • The successful outcome underscores the multidisciplinary approach required for managing advanced cardiovascular diseases.
Abstract

More Related Videos

Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation06:13

Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation

Published on: June 20, 2018

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...